Jong Duk Kim

Jong Duk Kim

Auto-generated profile, based on publicly available information

Jong Duk Kim

Department of Cardiothoracic Surgery, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2021 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
JKJong Duk Kim
Jong Duk Kim
Background: Esophageal perforation and rupture (EPR) is a serious, potentially life-threatening condition. However, no treatment methods have been established, and data concerning factors affecting mortality are limited. This report presents the prognostic factors of mortality in EPR based on experience in the management of such patients. Methods: For this retrospective analysis, 79 patients diagnosed as having EPR between 2006 and 2016 and managed at Gyeongsang National University Hospital were examined. The management method was determined in accordance with the location and size of the EPR, laboratory findings, and radiological findings. Thirty-nine patients were treated with surgery; and 40, with nonsurgical management. Results: The most common cause of EPR was foreign body (fish bone or meat bone), followed by vomiting, iatrogenic causes, and trauma. Thirty-nine patients underwent primary repair of EPR, of whom 4 patients died. Forty patients underwent nonsurgical management, of whom 3 patients died. The remaining patients were discharged. Mortality correlated with the size of the EPR (> 25 mm) and the segmented neutrophil count percentage (> 86.5%) in the white blood cell test and differential. Conclusions: The mortality risk was increased when the EPR size and the segmented neutrophil count percentage in the white blood cell test and differential was high. Delayed diagnosis, which was considered an important predictive factor in previous investigations, was not statistically significant in this study. Trial registration: Not applicable.

5 December 2019 in The Korean Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
HPHyun Oh Park
Hyun Oh Park
JCJun Young Choi
Jun Young Choi
IJIn Seok Jang
In Seok Jang
JKJong Duk Kim
Jong Duk Kim
JCJae Won Choi
Jae Won Choi
CLChung Eun Lee
Chung Eun Lee
Hyun Oh Park, M.D., Jun Young Choi, M.D., In Seok Jang, M.D., Jong Duk Kim, M.D., Jae Won Choi, M.D., Chung Eun Lee, M.D.. Korean J Thorac Cardiovasc Surg 2019;52:400-8. https://doi.org/10.5090/kjtcs.2019.52.6.400

1 January 2023 in Infection & Chemotherapy
Verified
Journal Article
Open access
KHKyung-Wook Hong
Kyung-Wook Hong
JYJung Wook Yang
Jung Wook Yang
JKJong Duk Kim
Jong Duk Kim
SJSunmi Ju
Sunmi Ju
MCMin-Chul Cho
Min-Chul Cho
IBIn-Gyu Bae
In-Gyu Bae
Hong KW, et al. Infect Chemother. 2023 Jan;55:e2. https://doi.org/10.3947/ic.2022.0128

1 January 2021 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
MKMin Hye Kim
Min Hye Kim
JNJi Min Na
Ji Min Na
GLGyeong-Won Lee
Gyeong-Won Lee
SLSeung Jun Lee
Seung Jun Lee
JKJong Duk Kim
Jong Duk Kim
JYJung Wook Yang
Jung Wook Yang

30 September 2020 in Medicina
Verified
Journal Article
Open access
PDF file
JBJoung Hun Byun
Joung Hun Byun
DKDong Hoon Kang
Dong Hoon Kang
JKJong-Woo Kim
Jong-Woo Kim
SKSung Hwan Kim
Sung Hwan Kim
SMSeong Ho Moon
Seong Ho Moon
CLChung Eun Lee
Chung Eun Lee
Patients with cardiopulmonary failure may not be fully supported with typical configurations of extracorporeal membrane oxygenation (ECMO), either veno-arterial (VA) or veno-venous (VV). Veno-arterial-venous (VAV)-ECMO is a technique used to support the cardiopulmonary systems during periods of inadequate gas exchange and perfusion. In the severe case of coronavirus disease 2019 (COVID-19), which simultaneously affects the heart and lung, VAV-ECMO may improve a patient’s recovery potential. We report the case of a 72-year-old woman with acute respiratory distress syndrome and circulatory failure following COVID-19, who was treated with VAV-ECMO.

5 January 2023 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
YLYong-Seong Lee
Yong-Seong Lee
JKJong Duk Kim
Jong Duk Kim
HPHyun-Oh Park
Hyun-Oh Park
CLChung-Eun Lee
Chung-Eun Lee
IJIn-Seok Jang
In-Seok Jang
JCJun-Young Choi
Jun-Young Choi
Yong-Seong Lee, M.D., Jong Duk Kim, M.D., Hyun-Oh Park, M.D., Chung-Eun Lee, Ph.D., In-Seok Jang, Ph.D., Jun-Young Choi, Ph.D.. J Chest Surg 2023;56:1-5. https://doi.org/10.5090/jcs.22.063